Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X-F Le

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|January 5, 1996
Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PMLX F Le, P Yang, K S Chang
Apoptosis : an International Journal on Programmed Cell Death|October 9, 2002
Heregulin-induced apoptosisX-F Le, C R Varela, R C Bast
Leukemia & Lymphoma|October 1, 1996
The biologic function of PML and its role in acute promyelocytic leukemiaZ M Mu, X F Le, A B Glassman, et al.
Chinese Medical Journal|November 1, 1990
Characteristics of paroxysmal nocturnal hemoglobinuria in China. Clinical analysis of 476 casesX F Le, T Y Yang, X Y Yang, et al.
Oncogene|May 16, 1998
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosisX F Le, S Vallian, Z M Mu, et al.
Carcinogenesis|December 12, 1997
Stable overexpression of PML alters regulation of cell cycle progression in HeLa cellsZ M Mu, X F Le, S Vallian, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Molecular approaches to management of epithelial ovarian cancerR. C. Bast, Y. Yu, F. -J. Xu, et al.
Dalton Transactions (Cambridge, England : 2003)|July 25, 2023
Hydrothermal conversion of mixed uranium(IV)-cerium(III) oxalates into U<sub>1-</sub>Ce<sub></sub>O<sub>2+</sub>·<i>n</i>H<sub>2</sub>O solid solutionsS Benarib, N Dacheux, X F Le Goff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expressionF Xu, Y Yu, X F Le, et al.
European Journal of Haematology|May 14, 1998
Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemiaX F Le, D Claxton, S Kornblau, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|January 5, 1996
Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PMLX F Le, P Yang, K S Chang
Apoptosis : an International Journal on Programmed Cell Death|October 9, 2002
Heregulin-induced apoptosisX-F Le, C R Varela, R C Bast
Leukemia & Lymphoma|October 1, 1996
The biologic function of PML and its role in acute promyelocytic leukemiaZ M Mu, X F Le, A B Glassman, et al.
Chinese Medical Journal|November 1, 1990
Characteristics of paroxysmal nocturnal hemoglobinuria in China. Clinical analysis of 476 casesX F Le, T Y Yang, X Y Yang, et al.
Oncogene|May 16, 1998
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosisX F Le, S Vallian, Z M Mu, et al.
Carcinogenesis|December 12, 1997
Stable overexpression of PML alters regulation of cell cycle progression in HeLa cellsZ M Mu, X F Le, S Vallian, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Molecular approaches to management of epithelial ovarian cancerR. C. Bast, Y. Yu, F. -J. Xu, et al.
Dalton Transactions (Cambridge, England : 2003)|July 25, 2023
Hydrothermal conversion of mixed uranium(IV)-cerium(III) oxalates into U<sub>1-</sub>Ce<sub></sub>O<sub>2+</sub>·<i>n</i>H<sub>2</sub>O solid solutionsS Benarib, N Dacheux, X F Le Goff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expressionF Xu, Y Yu, X F Le, et al.
European Journal of Haematology|May 14, 1998
Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemiaX F Le, D Claxton, S Kornblau, et al.
Pageof 2